Improving Inclusion and Applicability of Lifestyle Medicine Research in Viet Nam: Recruitment, Retention, and Equity-Focused Reporting
RESEARCH & IMPLEMENTATIONHEALTH EQUITY & PLANETARY HEALTH
11/22/202630 min read


Improving Inclusion and Applicability of Lifestyle Medicine Research in Viet Nam: Recruitment, Retention, and Equity-Focused Reporting
Last reviewed: November 22, 2026
A Lifestyle Medicine study reports encouraging results after participants complete a structured program involving nutrition counseling, physical activity support, and regular follow-up. The intervention appears feasible, participants describe positive experiences, and several health-related outcomes have improved.
Before considering whether these findings should influence routine healthcare, however, an important question deserves attention: Who actually participated in the research?
Most participants may have been recruited from a large urban hospital. Many may have had sufficient time to attend scheduled appointments, reliable access to smartphones, and the financial resources needed to follow the recommended activities. People working irregular hours, living far from the research facility, or experiencing difficulties with digital technology may have been less likely to enroll. Some participants may also have discontinued the intervention or become unavailable for follow-up.
These circumstances do not necessarily invalidate the study. A well-designed and appropriately conducted trial can provide credible evidence about an intervention under the conditions studied, even when participants differ from the wider population. However, such differences influence how the findings should be interpreted and where they may reasonably be applied.
This distinction matters in Lifestyle Medicine because interventions involving nutrition, physical activity, sleep, and other health behaviors are closely connected to everyday circumstances. People do not have equal access to suitable environments, resources, healthcare services, or opportunities to participate in structured programs.
An intervention that works well among participants with relatively favorable circumstances may also benefit people facing greater barriers. But that broader applicability should be examined rather than assumed.
For Viet Nam, improving the inclusion and applicability of Lifestyle Medicine research requires looking beyond the final number of participants. Researchers need to understand who was eligible, who was approached, who agreed to participate, who remained involved, and whose outcomes were ultimately represented in the analysis.
The objective is not to make every study statistically representative of the entire Vietnamese population. It is to produce reliable evidence for a clearly defined question while allowing clinicians, researchers, and healthcare leaders to understand which populations and circumstances the findings may reasonably inform.
Inclusion, Representativeness, and Applicability Are Different Concepts
Several terms are commonly used when discussing diversity in clinical research, but they describe different issues.
Inclusion concerns whether people relevant to the research question have a fair and meaningful opportunity to participate. This involves eligibility criteria, recruitment arrangements, accessibility of study procedures, and practical circumstances that may affect participation.
Representativeness concerns how closely a study sample reflects the characteristics of a defined population. In probability-based survey research, statistical representativeness may be supported by appropriate sampling methods, known selection probabilities, and suitable analysis.
Most clinical intervention studies, however, do not recruit participants through probability sampling from an entire population.
A randomized controlled trial may randomly allocate participants to different groups while relying on selective or convenience-based recruitment. Random allocation can strengthen the comparison between interventions, but it does not automatically make participants representative of everyone who might receive the intervention in routine care.
External validity concerns whether findings can reasonably be extended beyond the participants and conditions studied. Applicability is a related practical judgment about whether the results are relevant to a particular patient population, healthcare setting, or clinical decision.
These concepts overlap, but they are not interchangeable.
A study may have strong internal validity while leaving uncertainty about its application to people who were not recruited. Conversely, a study involving participants from diverse backgrounds may still have methodological weaknesses that limit confidence in its findings.
Increasing diversity cannot compensate for unreliable measurements, inappropriate comparisons, substantial missing data, or unsuitable statistical analysis.
For Lifestyle Medicine, the important question is whether the participants and study conditions provide a credible basis for understanding how an intervention may perform in the population and setting where its results are intended to be used.
Why Inclusion Matters in Lifestyle Medicine Research
Lifestyle Medicine interventions often depend on activities that extend beyond the healthcare facility.
A nutrition program may require participants to obtain particular foods, prepare meals, or modify household eating arrangements. A physical activity intervention may depend on access to safe environments, appropriate equipment, and time outside employment or caregiving responsibilities.
A sleep intervention may assume that participants have some control over their schedules. A digital behavior-change program may require a suitable device, reliable connectivity, and confidence using technology.
These assumptions may be reasonable for some people and difficult for others.
When recruitment procedures favor participants who can readily meet these requirements, the resulting study population may exclude individuals facing substantial barriers to implementing the intervention.
This can influence the usefulness of the findings.
The intervention may perform differently under less favorable circumstances. Alternatively, it may remain beneficial, but achieving comparable outcomes may require additional resources, different delivery arrangements, or more intensive professional support.
Neither possibility should be presumed without evidence.
The issue is therefore not simply whether a study includes participants from several demographic groups. Researchers should consider whether the characteristics and circumstances of participants are relevant to the research question and whether important differences could influence intervention effects, delivery, or interpretation.
A study focused on a clearly defined population does not need to recruit every possible patient group. However, unnecessary exclusion of people who could safely participate may limit the usefulness of the findings and raise concerns about fairness.
These considerations should begin during study design rather than emerge only after recruitment is complete.
What the 2026 Evidence Says About Reaching Underserved Populations
A systematic review of reviews by Pronk and colleagues, published in the International Journal for Equity in Health on May 7, 2026, examined strategies intended to reach, involve, and retain underserved populations in health intervention research.[1]
The review included 18 previous reviews covering different health conditions and populations. These included people experiencing socioeconomic disadvantage, racial or ethnic minority populations, individuals with lower literacy, and other groups facing barriers to healthcare or research participation.
The authors organized the identified strategies into approaches intended to encourage participation, facilitate involvement, and support retention.
Commonly discussed approaches included collaborating with community organizations, adapting communication, building trust, and providing more flexible participation arrangements.
However, the review also identified important limitations in the available evidence.
Only six of the 18 included reviews addressed retention strategies or factors associated with sustained participation. The evidence concerning the effectiveness of individual approaches was also limited.
These findings matter because strategies that appear practical or culturally appropriate are not necessarily proven to increase enrollment or prevent withdrawal.
Community partnerships may improve communication and study relevance without necessarily increasing recruitment. Translated materials may improve understanding without increasing enrollment. Flexible appointments may address a substantial barrier for some participants while having little effect for others.
The review supports a context-sensitive approach involving multiple strategies where appropriate, but it does not establish a universally effective recruitment or retention protocol.
Much of the underlying literature also concerned specific populations and health conditions outside Viet Nam.
Its findings provide useful considerations for local research planning, but they should not be interpreted as demonstrating that the same approaches will produce equivalent results in Vietnamese Lifestyle Medicine studies.
What the September 2026 Cochrane Review Adds
A major Cochrane review by Parker and colleagues, published on September 15, 2026, provides a more direct assessment of recruitment strategies evaluated experimentally.[2]
The review identified 91 eligible studies involving at least 176,747 participants and providing 94 comparisons of recruitment approaches.
The researchers evaluated 65 recruitment strategies. Many studies involved randomized methodological evaluations embedded within larger clinical trials, commonly described as Studies Within A Trial, or SWATs.
Despite the considerable volume of research, only five of the 65 strategies were supported by high-certainty evidence according to the review's GRADE assessments.
Importantly, high-certainty evidence did not always indicate that a strategy improved recruitment.
Telephone reminders to people who had not responded to an initial postal invitation increased recruitment by approximately six percentage points in the relevant comparisons. However, this finding concerned a specific recruitment context, primarily studies with relatively low underlying recruitment rates.
It should not be interpreted as evidence that telephone reminders will produce the same benefit in every population or healthcare setting.
The review also found that open-label trials recruited more participants than blinded, placebo-controlled trials in the comparisons examined. The estimated absolute difference was approximately ten percentage points.
However, blinding may be important for reducing bias, depending on the intervention, outcomes, and study design.
Researchers should not abandon scientifically or ethically appropriate blinding merely to increase enrollment.
Other strategies, including adding multimedia information to standard written materials, sending recruitment primer letters, and optimizing participant information leaflets through user testing, produced little or no difference in recruitment in the relevant high-certainty comparisons.
This finding requires careful interpretation.
Clear and accessible information remains essential for informed consent. The absence of a measurable recruitment benefit does not mean that understandable information is unimportant.
A procedure may be ethically necessary or valuable for participant comprehension without increasing the number of people who agree to join a study.
The review also identified substantial evidence gaps concerning recruitment costs, retention, and participant characteristics relevant to equity, diversity, and inclusion.
Almost all included studies were conducted in high-income countries. The evidence therefore provides limited direct support for assuming that recruitment strategies will have the same effects in countries with different healthcare systems, communication practices, and socioeconomic conditions.
Although the review was published in September 2026, its literature search extended through February 2023. Its conclusions should not be described as covering every recruitment experiment conducted through late 2026.
For Vietnamese researchers, the practical lesson is that recruitment methods should be chosen according to the barriers and circumstances of the intended population.
International findings can inform these choices, but they do not eliminate the need for local assessment.
Exclusion Can Begin Before Recruitment
Research exclusion can occur long before a potential participant receives an invitation.
Eligibility criteria determine who may enter a study, and some are necessary to protect participants or preserve scientific validity.
For example, an exercise intervention may require clinical assessment or exclusion criteria for individuals whose medical conditions make particular activities unsafe. A study evaluating a specific intervention may need to exclude people for whom it presents unacceptable risks.
These safeguards should not be removed merely to increase participant diversity.
Other restrictions, however, may arise primarily from operational convenience.
A study may require participants to attend appointments during working hours because the research team is available only at those times. It may exclude people unable to use smartphones even when the intervention could potentially be delivered through another suitable method.
A project may also restrict participation to individuals who can read one language because alternative communication arrangements were not developed.
These decisions influence who enters the study and may reduce the relevance of its findings to people receiving healthcare under different circumstances.
Researchers should therefore distinguish criteria necessary for participant safety or scientific validity from restrictions introduced mainly because of logistical limitations.
This does not mean every study must eliminate all practical constraints. Research resources are finite, and some operational requirements may be unavoidable.
The responsibility is to justify important exclusions, consider reasonable alternatives, and explain the limitations they create.
A study's intended population should be defined deliberately rather than becoming an unintended consequence of its recruitment procedures.
Defining the Population Before Planning Recruitment
Before recruiting participants, investigators should be able to explain whom the study is intended to inform.
A trial examining lifestyle support for adults with newly diagnosed hypertension may have a different target population from a program designed for older adults living with multiple chronic conditions.
A workplace intervention may be relevant to employees in particular industries or employment arrangements. A digital nutrition program may initially be intended for people who already use specific technologies.
These focused populations can be scientifically appropriate.
The problem arises when findings obtained from a narrowly defined population are later presented as applicable to everyone.
For example, an intervention evaluated mainly among digitally confident participants should not automatically be described as effective for all adults in Viet Nam.
Similarly, a program tested at a large urban hospital may provide valuable evidence without establishing that identical outcomes can be expected in provincial, community, or other healthcare settings.
The study should explain why its population was selected, how participants were identified, and which characteristics may influence the relevance of the findings elsewhere.
An appropriately narrow conclusion supported by reliable evidence is more useful than a broad claim extending beyond what the study can demonstrate.
Recruitment Should Be Understood as a Process
A study may report that it successfully recruited 300 participants. That number provides information about enrollment, but relatively little about inclusion.
To understand who participated, researchers need to examine the process that produced the final sample.
One study may screen a large population but enroll only a small proportion of eligible individuals. Another may enroll nearly everyone approached, but only after applying restrictive eligibility criteria.
These situations have different implications for research applicability.
Useful information may include the number of people assessed for eligibility, the number excluded, reasons for exclusion, the number invited, and the number who agreed to participate.
Where relevant and lawfully available, investigators may also examine whether recruitment patterns differ across characteristics associated with barriers to healthcare or research participation.
However, not every demographic or socioeconomic characteristic needs to be collected in every study.
The relevance of personal information depends on the research question, intended population, ethical considerations, and applicable data-protection requirements.
Researchers should also recognize that information about people who decline participation may be incomplete or unavailable.
Extensive identifiable information about nonparticipants should not be collected without an appropriate lawful and ethical basis.
Where the available information is limited, that limitation should be acknowledged rather than replaced with assumptions.
Transparent reporting of recruitment helps readers understand how the study population was formed and whether particular procedures may have discouraged otherwise eligible individuals from participating.
Recruitment Strategies Should Address Actual Barriers
A person may be interested in participating in a Lifestyle Medicine study but unable to attend repeated daytime appointments. Another may want to join but have difficulty understanding the study materials. Someone else may be concerned about confidentiality or uncertain whether declining research participation will affect their usual medical care.
These situations require different responses.
Flexible appointments may address scheduling difficulties. Accessible communication may improve understanding. Clear explanations about voluntary participation may help people distinguish research from routine treatment.
Community engagement may support communication and improve the relevance of study procedures.
However, these strategies should be selected according to the barriers actually encountered.
Researchers should avoid assuming that a method successful elsewhere will necessarily increase participation in their own setting.
Where feasible, a pilot study or methodological evaluation embedded within a larger project can help determine whether a particular recruitment approach is useful locally.
The purpose should not be to maximize enrollment regardless of suitability.
Appropriate recruitment means giving eligible individuals a fair opportunity to make an informed and voluntary decision about participation.
A strategy that increases enrollment by creating confusion, inappropriate pressure, or unrealistic expectations cannot be considered successful simply because more people agree to join.
Community Engagement Should Be More Than a Recruitment Channel
Working with community organizations, healthcare providers, and patient representatives can help researchers understand barriers that might otherwise be overlooked.
Community members may explain why proposed study visits are inconvenient, why particular terms are difficult to understand, or why certain communication channels do not reach the intended population.
They may also identify concerns about confidentiality, participant burden, and the relevance of the research question.
The World Health Organization's Guidance for Best Practices for Clinical Trials, published in September 2024, emphasizes meaningful participant and community engagement and the importance of strengthening equitable clinical research systems.[3]
The World Medical Association's revised Declaration of Helsinki, adopted in October 2024, also recognizes meaningful engagement with potential participants and communities throughout the research process.[4]
Community engagement should not be reduced to obtaining access to potential recruits.
A community organization should not simply become a channel for persuading people to enroll.
Meaningful participation may involve discussing research priorities, study procedures, participant burdens, communication methods, and how findings will eventually be shared.
Researchers should also recognize that no single community representative can speak for every individual.
Differences in age, disability, language, socioeconomic circumstances, and personal experiences may influence what people consider important.
Community involvement can improve the relevance and acceptability of research, but it does not automatically increase enrollment, eliminate selection bias, or establish statistical representativeness.
Its contribution should be described according to what was actually undertaken and what the available evidence supports.
Accessible Information and Voluntary Consent
Research participation requires an appropriate informed-consent process wherever consent is legally and ethically required.
The purpose is not merely to obtain a signature.
Potential participants should have a meaningful opportunity to understand the study's purpose, procedures, foreseeable risks, potential benefits, relevant alternatives, and the voluntary nature of participation.
They should also understand what may happen if they decline or later withdraw, subject to the applicable protocol and legal requirements.
Accessible communication can support this process.
Some individuals may benefit from plain-language explanations, additional time to consider participation, appropriate interpretation, or alternative communication formats.
People with disabilities may require arrangements reflecting their individual needs and preferences.
Disability should not automatically be equated with an inability to provide informed consent. Decision-making capacity and applicable legal representation requirements need to be considered according to individual circumstances and relevant law.
Researchers should also avoid assuming that translating a document is sufficient.
Technical terminology and culturally specific concepts may require additional explanation. Where research instruments or intervention materials are translated, their suitability for the intended purpose should be assessed.
Consent must remain free from inappropriate pressure.
Participation should not be presented as a condition for receiving ordinary, clinically indicated healthcare.
A clinician's position of professional authority should not be used to make a patient feel obliged to join a research project.
These principles apply whether research takes place in a large hospital, an outpatient clinic, or a community setting.
Participation Costs and Practical Support
Research can create financial and practical burdens that influence who is able to participate.
Participants may incur transportation expenses, lose income because of time away from work, or need assistance with childcare and other responsibilities.
A study requiring repeated travel may unintentionally favor people with greater financial resources or more flexible schedules.
Where appropriate, research teams may consider lawful and ethically acceptable arrangements for reimbursement or other practical support.
However, reimbursement and financial incentives serve different purposes.
Reimbursing reasonable participation-related expenses may reduce an existing barrier. Offering substantial financial rewards may create additional ethical concerns, particularly when participants experience financial hardship or other vulnerabilities.
Payments should not be designed or presented in ways that create inappropriate pressure to enroll or remain in research.
The amounts, conditions, and arrangements should be assessed according to the study's risks, participant population, and applicable institutional requirements.
Practical support should not automatically be described as a proven solution to underrepresentation.
The 2026 Cochrane review identified limited evidence concerning recruitment costs and equity-related outcomes.[2]
Researchers should therefore consider both the ethical justification for participation support and its actual effects on recruitment and continued involvement.
Retention Is Different From Intervention Adherence
Recruiting participants is only the beginning of a longitudinal study.
Lifestyle Medicine interventions may require follow-up over several months or longer periods. Some participants may stop attending intervention sessions while continuing to provide outcome information. Others may remain involved in the program but miss scheduled research assessments.
These situations should not be treated as identical.
Intervention adherence concerns the extent to which participants engage with or undertake the assigned intervention.
Retention generally concerns continued participation in relevant study activities, particularly follow-up assessments, although precise definitions vary between studies.
Outcome ascertainment concerns whether the information needed to evaluate study outcomes is obtained.
A participant may discontinue the assigned lifestyle intervention while remaining willing to provide information for the study.
Depending on the research design and the effect being estimated, this information may be important for understanding the consequences of assigning the intervention under realistic conditions.
However, continued data collection must respect the participant's consent, withdrawal preferences, and applicable legal requirements.
Researchers should not pressure individuals to remain in a study simply because withdrawal might reduce statistical power or complicate analysis.
Likewise, someone who finds an intervention difficult should not automatically be described as unmotivated or noncompliant.
The study procedures themselves may impose substantial burdens.
Distinguishing adherence from retention helps research teams understand whether participants are discontinuing the intervention, declining further research contact, or encountering difficulties completing particular assessments.
Each situation may require a different response.
What Evidence Supports Retention Strategies?
The 2026 review by Pronk and colleagues found that research involving underserved populations has focused much more heavily on initial recruitment than on maintaining participation.[1]
Only a minority of the included reviews addressed retention, and the available evidence did not establish one consistently effective strategy across populations and settings.
A Cochrane review by Gillies and colleagues, published in 2021, specifically examined interventions intended to improve retention in randomized trials.[5]
The review identified 81 retention trials and reported 52 intervention comparisons. None of the comparisons was supported by high-certainty evidence according to the authors' GRADE assessments.
Many studies focused on improving responses to postal questionnaires rather than attendance at clinical follow-up visits.
This distinction is important for Lifestyle Medicine research.
A strategy that increases questionnaire returns does not necessarily improve long-term follow-up in a program requiring clinical measurements, in-person assessments, or repeated behavioral support.
The effectiveness of reminders, alternative contact methods, flexible appointments, and other arrangements may depend on the study design and participants' circumstances.
Researchers should therefore plan retention procedures deliberately and, where appropriate, evaluate their effects.
They should also consider whether follow-up requirements are proportionate to the information needed.
A lengthy questionnaire repeated frequently may create more difficulty than a focused assessment designed around the study's most important outcomes.
Reducing unnecessary research burden may make participation more manageable, provided the scientific and safety requirements are preserved.
Missing Data Can Change the Meaning of Results
Loss to follow-up is not merely an administrative problem.
It can influence how study findings are interpreted.
Consider a Lifestyle Medicine intervention in which most participants who remain involved report favorable outcomes.
If people who discontinue follow-up differ systematically from those who remain, results based only on participants with complete data may provide a distorted picture.
Individuals experiencing substantial difficulty following the intervention may be more likely to stop responding.
Alternatively, participants who believe they have improved and no longer require support may be less likely to return for assessment.
The direction of potential bias cannot be determined from the number of missing observations alone.
The reasons data are missing matter, although those reasons are often incompletely known.
Statistical methods may help address missing data under appropriate assumptions. Depending on the study, these may include likelihood-based methods, multiple imputation, weighting, or other analytical approaches.
However, no statistical method can guarantee recovery of information that was never collected.
The credibility of an analysis depends on the assumptions underlying its methods, some of which may be difficult to verify.
Researchers should therefore explain how missing data were handled and conduct appropriate sensitivity analyses when relevant.
Reporting outcomes only among participants who completed every follow-up assessment may be inadequate, particularly when attrition is substantial or differs between study groups.
At the same time, an arbitrary universal threshold for acceptable loss to follow-up should not replace assessment of the study's actual risk of bias.
The importance of missing data depends on their extent, patterns, causes, and potential influence on estimated intervention effects.
Equity-Focused Retention Requires More Than an Overall Rate
A study may report a high overall retention rate while particular groups experience substantially greater loss to follow-up.
Participants living near the research facility may complete most assessments, while those traveling long distances may be less likely to return.
People with flexible employment may remain involved more easily than those whose work schedules change frequently.
If these differences are relevant to the research question, aggregate retention figures may conceal important barriers.
Where ethically appropriate and supported by sufficiently reliable data, researchers may examine whether retention patterns differ across selected population characteristics.
However, such analyses require caution.
Small subgroup numbers can produce unstable estimates. Certain combinations of personal characteristics may also create risks of identifying individuals, particularly in small communities or specialized clinical populations.
Researchers should use proportionate methods and appropriate confidentiality safeguards.
The purpose is to understand whether research procedures create unequal burdens, not to classify participants unnecessarily.
When differential attrition is identified, its implications for both analysis and applicability should be considered.
A study that retains participants with certain advantages more successfully may become less informative about the intended wider population as follow-up progresses.
This remains a concern even when the original recruitment process was relatively inclusive.
Inclusion Does Not Require Every Study to Represent Everyone
An inclusive study does not necessarily need to enroll participants reflecting the demographic distribution of an entire country.
The appropriate population depends on the research question.
An intervention developed for adults with a particular rehabilitation need should not be expected to represent all Vietnamese adults. Research examining a specific condition, age group, or clinical setting may legitimately use a focused population.
The important questions are whether eligibility criteria are scientifically justified, whether eligible individuals have a fair opportunity to participate, and whether conclusions remain within the scope supported by the evidence.
Statistical representativeness is not achieved simply by setting recruitment quotas for demographic characteristics.
Sampling methods, participation mechanisms, selection probabilities, and other design features influence whether results can be generalized to a defined population.
For intervention studies, applicability may require additional judgments about population characteristics, healthcare settings, intervention delivery, and factors that could modify treatment effects.
A multicenter study including participants from several provinces may still use highly selective recruitment procedures.
Conversely, a well-conducted single-center study may provide valuable evidence for the population and setting it was designed to examine.
The appropriate response is not to dismiss focused studies.
It is to describe their scope accurately and avoid unsupported claims about broader applicability.
Using PROGRESS-Plus to Consider Health Equity
Researchers may find structured frameworks useful when identifying population characteristics relevant to health equity.
The PROGRESS-Plus framework is widely used in evidence synthesis and health equity research.[6]
PROGRESS refers to place of residence; race, ethnicity, culture, or language; occupation; gender or sex; religion; education; socioeconomic status; and social capital.
The Plus component recognizes additional characteristics that may influence health opportunities, including age, disability, relationship-related circumstances, and factors that change over time.
The framework helps researchers consider where differences in access, participation, and health outcomes may arise.
It does not require every study to collect every characteristic.
Some factors may be highly relevant to a particular question and unnecessary for another. Their meaning and appropriateness can also differ across countries and cultural settings.
Researchers should be careful about importing classifications developed elsewhere without considering whether they are meaningful and suitable in Viet Nam.
The collection of information concerning ethnicity, disability, socioeconomic circumstances, religion, or other potentially sensitive characteristics requires a clear research purpose and appropriate safeguards.
The categories used should be defined transparently and interpreted carefully.
Researchers should also avoid treating social characteristics as biological explanations when the relevant mechanisms may involve access to healthcare, financial resources, environmental conditions, discrimination, or other structural influences.
PROGRESS-Plus can guide thoughtful consideration of equity.
It does not independently establish which characteristics influence intervention effectiveness or prove that a study is inclusive.
Subgroup Findings Need Careful Interpretation
Equity-focused research may examine whether an intervention produces different effects across population groups.
Such analyses can be useful when the differences are clinically or socially important.
However, subgroup findings are vulnerable to misinterpretation.
A common error is to conclude that an intervention works for one group but not another simply because its effect is statistically significant in one subgroup and not statistically significant in the other.
That comparison does not establish that the treatment effects differ.
An appropriate assessment generally requires examining the difference between treatment effects, often through a statistical interaction analysis.
The credibility of subgroup findings also depends on whether the analysis was specified in advance, supported by a plausible rationale, and based on adequate data.
Small samples may produce imprecise estimates. Examining many subgroups increases the likelihood of identifying apparently important differences by chance.
Researchers should distinguish prespecified analyses from exploratory findings and report the uncertainty surrounding their estimates.
A failure to detect a subgroup difference does not prove that treatment effects are identical.
Similarly, an exploratory finding should not automatically become a recommendation to provide or withhold an intervention from a particular population.
For Lifestyle Medicine, these considerations are relevant when examining differences associated with age, sex, disability, socioeconomic circumstances, or geographical location.
Equity-focused analysis should strengthen scientific understanding rather than create unsupported assumptions about who can benefit.
Reporting Guidelines Help Readers Understand Who Was Studied
Transparent reporting is essential for interpreting the inclusion and applicability of research findings.
The CONSORT 2025 statement, published in The BMJ in April 2025, provides updated guidance for reporting randomized trials.[7]
It contains a 30-item checklist and a participant flow diagram.
The update strengthens several aspects of reporting relevant to research inclusion, including patient and public involvement, eligibility criteria, study sites, intervention delivery, missing data, and participant flow.
These details help readers understand how a study was conducted and whether its findings may be relevant to other populations and settings.
Eligibility criteria for participating facilities and intervention providers may reveal that a trial depended on specialized resources unavailable in many routine healthcare settings.
Participant flow information may identify substantial exclusions before enrollment or losses after randomization.
Clear reporting of missing-data methods allows readers to examine whether incomplete observations may have affected estimated outcomes.
However, CONSORT 2025 remains a reporting guideline.
It does not independently establish that a trial was well designed, free from bias, or representative of a defined population.
A study can follow the reporting checklist while transparently describing important methodological limitations.
That transparency is valuable because it allows readers to evaluate the evidence more accurately.
For studies specifically examining health equity, additional guidance is available.
The CONSORT-Equity 2017 extension was developed to improve reporting in randomized trials where health equity considerations are relevant.[8]
It encourages clearer descriptions of populations experiencing disadvantage, recruitment procedures, subgroup analyses, ethical considerations, and the implications of findings for equity.
The extension was developed in relation to CONSORT 2010.
Because CONSORT 2025 has superseded CONSORT 2010, researchers should use the current CONSORT statement as the principal reporting framework while considering the relevant equity-specific principles from CONSORT-Equity.
The existence of the earlier extension should not be interpreted as evidence that every item has been formally updated or revalidated for CONSORT 2025.
For observational research, another important development occurred in September 2025.
Dewidar and colleagues published the STROBE-Equity extension in The BMJ and JAMA Network Open.[9]
The extension was developed to improve reporting of health equity considerations in observational studies, including how relevant populations, data, methods, and limitations are described.
It should be considered alongside the main STROBE statement when appropriate.
This may be particularly useful when researchers analyze routinely collected healthcare data that contain incomplete or inconsistent information about socioeconomic circumstances or other equity-related characteristics.
The guidance does not authorize collection of sensitive information without an appropriate research purpose and legal or ethical justification.
Its value lies in encouraging researchers to explain which information was available, how relevant characteristics were defined, and what limitations may affect the conclusions.
These reporting resources are complementary. None replaces rigorous study design, reliable analysis, or applicable ethical review.
Consider Applicability Before the Study Begins
Research applicability is often discussed only after results become available.
By then, some important limitations may be difficult to address.
If a study recruited exclusively from a specialized urban center, subsequent analysis cannot automatically recreate the experiences of people who were never eligible or approached.
If an intervention depended on frequent specialist consultations, the findings may not establish how it would perform under a less intensive service model.
These issues deserve attention during protocol development.
The SPIRIT 2025 statement, published in April 2025, provides updated guidance for randomized trial protocols.[10]
Its 34-item checklist includes attention to eligibility criteria, participant and public involvement, intervention descriptions, outcome assessments, and planned methods for addressing missing data.
A protocol provides an opportunity to consider inclusion before recruitment begins.
Researchers can examine whether eligibility criteria are justified, whether study procedures are feasible, whether participation barriers have been considered, and whether selected outcomes are meaningful for the intended population.
They can also specify how recruitment and retention will be monitored and how incomplete information will be addressed.
However, a complete protocol does not guarantee that research will be conducted successfully.
It supports planning and transparency, while the credibility of the final evidence still depends on how the study is implemented, analyzed, and reported.
A Hypothetical Lifestyle Medicine Study in Viet Nam
Consider a hypothetical multicenter study evaluating a structured Lifestyle Medicine support program for adults receiving outpatient care for hypertension.
The research team initially plans to recruit participants from two urban clinics. The intervention involves scheduled counseling sessions and digital follow-up questionnaires.
During protocol development, the investigators recognize that the proposed procedures may be easier for people living near the clinics and those comfortable using smartphones.
They reconsider the population they intend to study.
If the objective is to evaluate the program among patients routinely receiving care at those urban facilities, the recruitment design may be appropriate, provided the findings are interpreted within that context.
If the researchers intend to inform broader healthcare delivery, additional settings or alternative participation arrangements may be necessary.
The team considers whether a provincial or community healthcare facility could participate and whether follow-up could be completed through different suitable methods.
These decisions would need to reflect the research question, available resources, clinical requirements, and methodological design.
Eligibility criteria are reviewed to identify restrictions that are not necessary for scientific validity or participant safety.
Appropriate clinical safety criteria remain in place.
The researchers also examine whether recruitment materials are understandable and whether potential participants have sufficient opportunity to ask questions before deciding.
A suitable informed-consent process is established, with particular attention to voluntary participation and the distinction between research and routine medical care.
During recruitment, the team documents participant flow and relevant reasons for exclusion.
Where lawful, ethical, and scientifically appropriate, investigators examine whether enrollment differs across selected characteristics relevant to the intended population.
Follow-up procedures are designed to reduce avoidable burdens.
Participants who discontinue the assigned lifestyle intervention are not automatically treated as having withdrawn from every research activity. Continued outcome assessment, where appropriate, is managed according to the study protocol, consent arrangements, and applicable requirements.
During analysis, the team examines missing information and conducts appropriate sensitivity analyses.
The final report describes the study population, recruitment procedures, participant losses, intervention delivery, and limitations on applicability.
If favorable outcomes are observed, the researchers do not claim that the intervention has been proven effective for every Vietnamese adult with hypertension.
They explain what the study supports and where additional research may be needed.
This example is hypothetical. It is not a validated Vietnamese research protocol, an approved clinical trial, or a study already conducted or formally endorsed by VLMA.
Any actual project would require appropriate methodological, clinical, institutional, ethical, and regulatory assessment.
Ethical Inclusion Requires Appropriate Participant Protection
Efforts to improve inclusion should never weaken participant protection.
The 2024 revision of the Declaration of Helsinki emphasizes respect for research participants' rights, dignity, autonomy, privacy, and confidentiality.[4]
It also recognizes the importance of addressing structural inequities and engaging participants and communities meaningfully.
These principles are relevant to Lifestyle Medicine research, particularly where studies involve people experiencing socioeconomic disadvantage, disability, limited access to healthcare, or other circumstances affecting participation.
However, inclusion does not mean every person should be enrolled regardless of clinical risk.
Some exclusions are necessary to protect participants.
The ethical objective is to avoid unjustified exclusion while maintaining scientifically appropriate safeguards.
Greater enrollment should not be achieved through misleading information, inappropriate incentives, or pressure from healthcare professionals.
Potential participants should understand that declining research participation does not automatically mean declining ordinary medical care.
Their consent and withdrawal rights must be respected according to applicable requirements.
Research teams should also consider the burdens created by study procedures.
Repeated travel, intrusive monitoring, lengthy questionnaires, or demanding follow-up schedules may disproportionately affect people with limited time and resources.
Ethically responsible research requires examining whether these burdens are justified by the scientific value of the study and whether they can be reduced without compromising necessary safeguards.
The Vietnamese Regulatory Context
Biomedical research in Viet Nam operates within applicable national laws, institutional requirements, and research governance arrangements.
Ministry of Health Circular No. 43/2024/TT-BYT, issued on December 12, 2024, and effective February 1, 2025, regulates the establishment, organization, and operation of ethics committees in biomedical research.[11]
The Circular addresses the relevant responsibilities, organization, and operation of these committees within its defined regulatory scope.
It should not be described as a single comprehensive law governing every possible research activity or as establishing identical review requirements for all observational studies, clinical trials, and routine quality-improvement projects.
The applicable approval and oversight requirements depend on the purpose, activities, risks, and design of the project, together with other relevant legal and institutional provisions.
Where research involves regulated medical examination, treatment, or other healthcare activities, the Law on Medical Examination and Treatment No. 15/2023/QH15, as amended, and its implementing regulations remain relevant.[12]
Research participation does not independently authorize a healthcare professional to perform clinical activities outside their lawful professional scope.
Similarly, international collaboration does not automatically establish permission to conduct regulated clinical activities or research in Viet Nam.
Before recruiting participants, the responsible institution should determine which approvals, professional qualifications, ethical safeguards, and organizational arrangements apply.
International research guidelines and ethical declarations can provide important professional reference points, but they do not independently establish Vietnamese regulatory approval or legal authority.
Data Protection and Equity-Focused Reporting
Inclusive research may involve collecting information about geographical location, employment, disability, socioeconomic circumstances, language, or other characteristics relevant to research participation and outcomes.
Such information may help investigators identify barriers or assess differences between population groups.
However, it can also create privacy and confidentiality risks.
Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 entered into effect on January 1, 2026.[13]
Government Decree No. 356/2025/NĐ-CP, effective on the same date, provides additional implementing requirements.[14]
Decree No. 102/2025/NĐ-CP, effective July 1, 2025, regulates health data management within its applicable scope.[15]
Organizations conducting research must determine the lawful basis and purpose for processing identifiable information and implement appropriate safeguards concerning collection, access, storage, disclosure, retention, and security.
The desire to improve equity reporting does not authorize unrestricted collection of sensitive personal information.
Researchers should collect information relevant and justified for the intended scientific purpose.
They should also consider whether findings can be reported in ways that protect participants while preserving useful information.
Aggregated reporting may reduce some privacy risks, but small population groups can remain identifiable in particular circumstances.
This is especially important when reporting combinations of characteristics from small communities or specialized patient populations.
International research collaborations may require additional assessment of data-sharing arrangements, access rights, and cross-border processing obligations.
Removing names from a dataset does not automatically resolve every legal or ethical concern.
Responsible data governance is part of trustworthy equity-focused research.
Building Capacity for More Applicable Research in Viet Nam
Improving inclusion is not solely the responsibility of staff conducting recruitment.
It also depends on institutional support, research funding, methodological expertise, and the organization of study procedures.
A research team may recognize that flexible follow-up arrangements would improve accessibility but lack the resources needed to provide them.
A healthcare facility may wish to engage a broader population but have limited experience with accessible communication or meaningful community partnerships.
Researchers may also require support in selecting appropriate equity-related variables, handling missing data, and interpreting subgroup findings.
These are research capacity issues.
International collaboration can create opportunities to strengthen methods, share experience, and conduct multicenter studies.
However, such collaboration should allow Vietnamese institutions and researchers to contribute meaningfully to research priorities, study design, implementation, analysis, and publication.
Local participation should not be limited to recruiting participants for protocols developed elsewhere.
Research questions should reflect the needs of the people and healthcare settings the findings are intended to inform.
Capacity development may include training in research methodology, participant communication, ethics, data governance, and transparent reporting.
It may also involve developing practical systems for monitoring recruitment and follow-up.
These activities should remain proportionate to the scale and purpose of the study.
A carefully designed pilot may provide valuable information about participation barriers and operational feasibility without claiming to establish broad clinical effectiveness.
Larger studies may then be justified when important uncertainties remain.
The objective should be to strengthen the quality and relevance of the evidence, not merely increase the number of research projects.
Better Evidence Begins With Understanding Who It Is For
Lifestyle Medicine research seeks to inform decisions about interventions that people undertake in their everyday lives.
For that evidence to be useful, researchers need to understand more than whether an intervention produced favorable outcomes among the participants studied.
They also need to know who could participate, who remained involved, which barriers affected participation, and how those circumstances influence the applicability of the findings.
The international evidence published in 2025 and 2026 reinforces the importance of these questions.
The review by Pronk and colleagues identifies approaches that may help researchers reach and involve underserved populations while highlighting the limited evidence specifically addressing retention.
The September 2026 Cochrane review demonstrates that many recruitment strategies remain insufficiently evaluated and that much of the stronger evidence comes from high-income settings.
CONSORT 2025 and SPIRIT 2025 provide updated resources for transparent trial reporting and protocol development. CONSORT-Equity and STROBE-Equity offer additional guidance when health equity considerations are relevant to the research question.
Together, these resources support a more deliberate approach to inclusion and applicability.
For Viet Nam, this does not mean every Lifestyle Medicine study must attempt to recruit a sample representing the entire country.
It means investigators should define the intended population, justify eligibility criteria, examine avoidable barriers, protect voluntary participation, and report findings in a way that allows others to understand their scope.
Recruitment should be considered alongside retention. Participant inclusion should be considered alongside scientific validity. Equity-focused analysis should be accompanied by methodological caution, and all research activities must remain consistent with applicable ethical, legal, and professional responsibilities.
For the Vietnam Lifestyle Medicine Alliance (VLMA), this topic is consistent with advancing evidence-based Lifestyle Medicine through professional education, scientific knowledge exchange, research capacity development, and responsible international collaboration.
The role of a professional educational platform is not to establish a separate national research approval system, certify that studies are representative, or imply that international reporting guidelines automatically have regulatory authority in Viet Nam.
It is to promote a clearer understanding of what trustworthy research requires and how its findings can be interpreted responsibly.
A strong study does not need to answer every question for every population. It needs to answer its intended question well, explain who the findings concern, and acknowledge where important uncertainty remains.
Improving inclusion and applicability ultimately means making research more informative about the people whose healthcare it is intended to support.
That is an important foundation for more credible, equitable, and evidence-based Lifestyle Medicine research in Viet Nam.
References and Further Reading
Pronk J, Ivanova H, Harakeh Z, Schuller A, van Empelen P, van Keulen H. Strategies to reach, involve, and maintain underserved populations in health intervention research: a systematic review of reviews. International Journal for Equity in Health. 2026;25:159. Published May 7, 2026. doi:10.1186/s12939-026-02858-3.
Parker A, Mongelli G, Piccolo-Lawrance C, et al. Strategies to improve recruitment to randomised trials. Cochrane Database of Systematic Reviews. 2026;9:MR000013. Published September 15, 2026. doi:10.1002/14651858.MR000013.pub7.
World Health Organization. Guidance for Best Practices for Clinical Trials. Geneva: World Health Organization; 2024. ISBN: 978-92-4-009771-1.
World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA. 2025;333(1):71–74. Revised and adopted October 2024. doi:10.1001/jama.2024.21972.
Gillies K, Kearney A, Keenan C, et al. Strategies to improve retention in randomised trials. Cochrane Database of Systematic Reviews. 2021;3:MR000032. doi:10.1002/14651858.MR000032.pub3.
Welch VA, Petkovic J, Jull J, et al. Equity and specific populations. In: Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024. Chapter 16, last updated October 2019.
Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025;389:e081123. Published April 14, 2025. doi:10.1136/bmj-2024-081123.
Welch VA, Norheim OF, Jull J, et al. CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials. BMJ. 2017;359:j5085. doi:10.1136/bmj.j5085.
Dewidar O, Shamseer L, Melendez-Torres GJ, et al. Improving the reporting on health equity in observational research (STROBE-Equity): extension checklist and elaboration. BMJ. 2025;390:e083882. Published September 3, 2025. doi:10.1136/bmj-2024-083882.
Chan AW, Boutron I, Hopewell S, et al. SPIRIT 2025 statement: updated guideline for protocols of randomised trials. BMJ. 2025;389:e081477. Published April 28, 2025. doi:10.1136/bmj-2024-081477.
Ministry of Health of Viet Nam. Circular No. 43/2024/TT-BYT, dated December 12, 2024, regulating the establishment, organization, and operation of ethics committees in biomedical research. Effective February 1, 2025.
National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15, dated January 9, 2023, as amended, together with applicable implementing regulations.
National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15, dated June 26, 2025. Effective January 1, 2026.
Government of Viet Nam. Decree No. 356/2025/NĐ-CP, dated December 31, 2025, detailing selected provisions and implementation measures of the Law on Personal Data Protection. Effective January 1, 2026.
Government of Viet Nam. Decree No. 102/2025/NĐ-CP, dated May 13, 2025, on Health Data Management. Effective July 1, 2025.
Editorial, Research Ethics and Regulatory Note
This article is published by the Vietnam Lifestyle Medicine Alliance (VLMA) for professional education, scientific knowledge exchange, and discussion of responsible approaches to improving inclusion, participant retention, research applicability, and equity-focused reporting in Lifestyle Medicine research in Viet Nam.
It reviews selected international methodological research, research ethics principles, reporting guidance, and relevant Vietnamese regulatory considerations. It is not a Vietnamese national research guideline, an approved study protocol, a research ethics approval, a professional licensing standard, or an authoritative legal opinion.
The recruitment, retention, and reporting approaches discussed in this article are intended to support scientific understanding. They are not presented as universally effective strategies, validated Vietnamese recruitment protocols, or methods that guarantee statistical representativeness.
Greater diversity among research participants does not automatically establish that a sample is representative of a defined population, that an intervention has equal effects across population groups, or that findings can be generalized without further assessment.
The applicability of research findings depends on the research question, participant characteristics, study design, intervention, setting, methods, and available evidence.
Recruitment and retention activities must respect voluntary participation, informed consent where required, confidentiality, participant safety, and applicable withdrawal rights.
Efforts to improve inclusion must not justify inappropriate recruitment pressure, removal of necessary clinical safety criteria, unauthorized access to medical records, or collection of unnecessary sensitive personal information.
Clinical interventions, treatment decisions, and other regulated healthcare activities undertaken during research must remain within the lawful authority of appropriately qualified healthcare professionals and institutions.
Research involving human participants must comply with the ethical, regulatory, and institutional requirements applicable to its actual purpose, design, and activities.
The collection, processing, sharing, storage, and publication of personal or health-related information must comply with applicable Vietnamese laws concerning personal-data protection, health-data management, and healthcare confidentiality.
International guidance, including WHO research recommendations, the Declaration of Helsinki, CONSORT, SPIRIT, CONSORT-Equity, and STROBE-Equity, is presented as scientific and professional reference material. These documents do not independently establish Vietnamese research approval requirements or confer regulatory authorization.
The hypothetical research example is illustrative. It does not describe an existing study, an approved research protocol, or a project already implemented or formally endorsed by VLMA.
VLMA does not independently approve biomedical research, grant ethics clearance, authorize clinical trials, certify research representativeness, license healthcare professionals, or establish nationally binding research standards through this article.
The scientific and regulatory materials referenced were reviewed through November 22, 2026. Researchers and institutions considering implementation should verify current legal requirements, appropriate ethical review arrangements, professional responsibilities, and the methodological suitability of their proposed studies.
Vietnam Lifestyle Medicine Alliance
Evidence-Based Lifestyle Medicine for Viet Nam.
Contact
contact@vlma.org
Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC
+84 909 228 476
+84 84 9999 911
© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.
A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.
VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.
VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.
VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.
